October 28, 2024
TOPLINE: Allogeneic bone marrow–derived mesenchymal stromal cells (BM-MSCs) are safe but do not show efficacy in treating intervertebral disc degeneration (IDD) in patients with chronic low […]
October 28, 2024
Abu Dhabi, UAE — Cerebrolysin, a porcine-derived collection of growth factors already employed for a broad array of neurodegenerative disorders in Asia and Eastern Europe, was […]
October 28, 2024
TOPLINE: Atezolizumab combined with targeted therapy improved median overall survival to 19 months in patients with anaplastic thyroid carcinoma (ATC). The longest survival was observed in […]
October 28, 2024
Current efforts to control high blood pressure (BP) are failing in the United States and globally. The first World Health Organization (WHO) global report on hypertension […]
October 28, 2024
US veterans were nearly three times more likely to develop skin cancer than the general population, according to a large cross-sectional analysis of recent national data. […]
October 28, 2024
TOPLINE: Taking screens away from toddlers an hour before bedtime resulted in slight improvements in sleep; however, this intervention did not have a significant impact on […]
October 28, 2024
TOPLINE: The extended-release fluticasone propionate injection (EP-104IAR) significantly reduces knee osteoarthritis (OA) pain over 12 weeks compared with a vehicle control, with no serious treatment-related adverse […]
October 28, 2024
Metabolic dysfunction–associated steatotic liver disease (MASLD) has become the most common liver disease worldwide, with a global prevalence of 32.4%. Its growth over the past three […]
October 28, 2024
Misinformation and outdated protocols contribute to the suboptimal management of anaphylaxis by patients and healthcare professionals, based on data from two new studies presented at the […]